Literature DB >> 5041485

The mode of action of -methyldopa.

M D Day, A G Roach, R L Whiting.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5041485      PMCID： PMC1666180     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  6 in total

1.  INHIBITION OF DOPAMINE-BETA-HYDROXYLASE BY DISULFIRAM.

Authors:  M GOLDSTEIN; B ANAGNOSTE; E LAUBER; M R MCKEREGHAM
Journal:  Life Sci (1962)       Date:  1964-07

2.  A hypothesis for the mode of action of alpha-methyldopa in relieving hypertension.

Authors:  M D DAY; M J RAND
Journal:  J Pharm Pharmacol       Date:  1963-04       Impact factor: 3.765

3.  Impairment of sympathetic nerve responses by dopa, dopamine and their alpha-methyl analogues.

Authors:  J B Farmer
Journal:  J Pharm Pharmacol       Date:  1965-10       Impact factor: 3.765

4.  Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.

Authors:  G Bartholini; A Pletscher
Journal:  J Pharmacol Exp Ther       Date:  1968-05       Impact factor: 4.030

5.  Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.

Authors:  M Henning
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1969

6.  SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA.

Authors:  M D DAY; M J RAND
Journal:  Br J Pharmacol Chemother       Date:  1964-02
  6 in total
  1 in total

1.  Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats.

Authors:  M D Day; A G Roach
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.